FOSRICH reports 52% decline in six months net profit

August 12, 2024

Fosrich Company Limited (FOSRICH) for the six months ended June 30, 2024, reported a 14% decrease in Revenue totalling $1.74 billion compared to $2.02 billion in the corresponding period last year. Revenue for the second quarter had a 6% decrease to close at $884.63 million compared to $940.85 million for the comparable quarter of 2023.

Cost of Sales amounted to $868.79 million (2023: $1.21 billion), this represents a decrease of 28% year over year. Consequently, gross profit increased by 7% to $875.67 million compared to $817.85 million for the six months ended June 30, 2023. The company booked gross profit of $486.12 million for the second quarter versus $371.84 million reported for the similar quarter of 2023.

Other Income increased by 244% to close at $8.58 million (2023: $2.50 million), while Administrative and other expenses increase by 25% from $526.74 million in 2023 to $656.63 million in the period under review. As a result, profit before depreciation and finance cost for the six months ended June 30, 2024, amounted to $227.62 million, a 22% decrease relative to $293.61 million reported in 2023.

Finance cost totalled $140.11 million a 30% increase from the corresponding period last year. (2023: $108.01 million).

Profit before taxation for the six months ended June 30, 2024, amounted to $87.50 million, a 53% decrease relative to $185.60 million reported in 2023. Profit before taxation for the second quarter amounted to $50.05 million (2023: $46.62 million). Taxation for the six months was $9.62 million (2023: $23.11 million).

Net profit for the six months amounted to $77.88 million, a 52% decrease from the $162.50 million reported in 2023. For the second quarter, Net profit was $44.89 million (2023: $40.77 million).

Consequently, Earnings Per Share for the six months amounted to $0.02 (2023: EPS: $0.03), while Earnings Per Share for the quarter totalled $0.01 (2023: EPS: $0.01). The twelve-month trailing EPS was $0.03, and the number of shares used in these calculations was 5,078,485,197.

Notably, FOSRICH’s stock price closed the trading period on August 9, 2024, at a price of $2.21 with a corresponding P/E ratio of 73.70x.

Balance Sheet Highlights

The company’s assets totalled $6.19 billion (2023: $5.08 billion). The increase in assets was attributable to an 875% jump in ‘due from related parties’ closing at $779.77 million.

Shareholder’s equity was $2.12 billion (2023: $1.94 billion), representing a book value per share of $0.42 (2023: $0.39).

Disclaimer:

Analyst Certification -The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation(s) or view (s) expressed by that research analyst in this research report.

Company Disclosure -The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may affect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein

More Stories from the Market
shutterstock_537598660
March12, 2026 Blue Power Group Limited (BPOW) Unaudited financials for the nine months ended January 31, 2026: Blue Power Group Limited (BPOW) for …
shutterstock_148562033
March 12, 2026   Wisynco Group Limited (WISYNCO) has advised that on March 9, 2026, Executives sold a total of 2,594,821 WISYNCO shares. …
shutterstock_453968572
March 12, 2026 United States: US Trade Gap Narrowed in January by More Than Projected   The US trade deficit narrowed in January as export…
shutterstock_342262439
March 11, 2025   Indies Pharma Jamaica Limited (INDIES) has advised that at a meeting of its Board of Directors to be held on March 23, 202…
shutterstock_453968572
March 11, 2025   Kintyre Holdings (JA) Limited (KNTYR) has advised that the Company has been notified that a group of principal shareholder…
shutterstock_148562033
March 11, 2026   A.S. Bryden & Sons Holdings Limited (ASBH) has advised that on February 16, 2026, a connected party purchased 282,704 …
shutterstock_148562033
March 11, 2025   Seprod Limited (SEP) has advised that on February 20, 2026, a Director sold 5,787,413 SEP shares and a connected party pur…
shutterstock_537598660
March 11, 2026 Weekly Pick 11.03.2026 JMMBGL Disclaimer: Analyst Certification -The views expressed in this research report accurately refl…